Android app Apple app link

Ultragenyx Pharmaceutical Inc. (RARE) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$38.87

south_east
-$0.43 (-1.1%)
Day's range
$38.54
Day's range
$39.33

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
11/06/2024 H.C. Wainwright Ed Arce $95.00 $51.20   85.55%
11/06/2024 Leerink Partners Joseph Schwartz $85.00 $51.20   66.02%
06/06/2024 Goldman Sachs Salveen Richter $67.00 $41.45   61.64%
05/31/2024 Stifel Nicolaus Dae Gon Ha $127.00 $38.65   228.59%
05/31/2024 Raymond James Christopher Raymond $135.00 $38.65   249.29%
05/31/2024 Robert W. Baird Joel Beatty $72.00 $38.65   86.29%
05/31/2024 Canaccord Genuity Whitney Ijem $111.00 $38.65   187.19%
04/15/2024 Stifel Nicolaus Dae Gon Ha $124.00 $42.87   189.25%
04/15/2024 Raymond James Christopher Raymond $130.00 $42.87   203.24%
07/28/2022 Piper Sandler Christopher Raymond $130.00 $51.88   150.58%
05/18/2022 Piper Sandler Christopher Raymond $135.00 $47.70   183.02%
01/09/2022 Cowen & Co. Yaron Werber $124.00 $73.10   69.63%
11/02/2021 Citigroup Yigal Nochomovitz $150.00 $86.00   74.42%
11/02/2021 Wedbush Laura Chico $92.00 $86.00   6.98%
09/26/2021 Piper Sandler Christopher Raymond $170.00 $88.66   91.74%
08/18/2021 UBS Esther Rajavelu $73.00 $77.92   -6.31%
08/02/2021 Barclays Gena Wang $141.00 $83.77   68.32%

Ultragenyx Pharmaceutical Inc. FAQ's

Ultragenyx Pharmaceutical Inc. has been rated by research analysts at Piper Sandler, Morgan Stanley, H.C. Wainwright, Leerink Partners, Goldman Sachs, Stifel Nicolaus in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.